| (Nanowerk News) Researchers from the IBB-UAB have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV2 virus particles, both in liquid solutions and on the surface of materials. These novel nanoparticles could be used to manufacture antiviral materials such as wastewater and air filters, and could be exploited to develop new tests for the early detection of Covid-19. Moreover, the nanoparticles could be redesigned to target other pathogens. | |
| The study was led by researchers from the Institute for Biotechnology and Biomedicine of the Universitat Autònoma de Barcelona (IBB-UAB), who highlight the potential of the developed nanostructures for the manufacturing of new antiviral materials. | |
| The study was published in the journal Advanced Healthcare Materials (“Protein Nanoparticles for Targeted SARS-CoV-2 Trapping and Neutralization»”). | |
| The new nanoparticles, called LCB1-NPs and LCB3-NPs, are formed by repeats of three proteins, which are joined together thanks to the self-assembly properties of one of the three, called ZapB. In the genetic engineering strategy that was implemented, the researchers fused ZapB with the mCherry protein, which confers red fluorescence to the nanoparticles, and to this union they added the LCB1 and LCB3 proteins, which provide the ability to bind and neutralise the SARS-CoV-2 virus. Thus, by forming these nanostructures, it was possible to localise all these functions in a single nanoparticle. | |
 |
|
| Illustration of the formation of the new nanoparticles, LCB1-NPs and LCB3-NPs, designed by the IBB-UAB researchers. (Image: IBB-UAB) | |
| The researchers underscore the high affinity of the nanoparticles to bind to the viral spike protein that allows SARS-CoV2 internalization into cells. This process enables the nanoparticles to neutralise the infection in both liquid solutions and immobilised on a surface. This demonstrates the great versatility of this new antiviral nanomaterial, paving the way for its utilisation in a multitude of applications. | |
| “Each nanoparticle is composed of many LCB1 or LCB3 proteins, resulting in a high density of SARS-CoV-2 binding sites that allow each nanoparticle to bind to more than one virus. This greatly increases their potential as an antiviral material compared to other materials in which each nanostructure can only bind to one single particle of the virus,” explains IBB-UAB researcher Marc Fornt, first author of the study. | |
| The red fluorescence makes it easier to track and localize the nanoparticles with the naked eye, which makes them much easier to handle. | |
| An experiment using the nanoparticles to engineer a virus filter has allowed the researchers to demonstrate the ability of this new nanomaterial to trap and neutralise large quantities of SARS-CoV-2. Among its applications are the filtering of wastewater containing secretions from patients affected by Covid-19 to prevent them from reaching the water system, and the filtering of air in sensitive areas such as hospital wards. The nanoparticles could also be used in the manufacturing of new ultra-sensitive detection tests to diagnose the disease in the early stages of infection, when the viral load is still very low. | |
| “These new nanoparticles are also of great interest for the industrial production of antiviral materials due to the simplicity, speed and low cost involved in making them,” says IBB-UAB researcher and director of I3PT Salvador Ventura, who coordinated the study. | |
| The modular system through which the nanostructures were generated allows the protein that recognises and neutralises SARS-CoV-2 to be replaced by proteins that recognise other pathogens of interest. “This flexibility provides a solid framework for the generation of new materials to combat potential emerging infectious diseases effectively and rapidly, particularly if combined with recent advances in de novo protein design,” concludes Salvador Ventura. |
| Source: Universitat Autònoma de Barcelona (Note: Content may be edited for style and length) |
News
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
